Home Cart Sign in  
Chemical Structure| 22862-76-6 Chemical Structure| 22862-76-6

Structure of Anisomycin
CAS No.: 22862-76-6

Chemical Structure| 22862-76-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Anisomycin is a naturally occuring antibiotic which can act as a potent activator of stress-activated protein kinases (JNK/SAPK) and p38 MAPK, and also can inhibit protein synthesis by blocking translation.

Synonyms: Flagecidin; Wuningmeisu C; AI3-50846

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Anisomycin

CAS No. :22862-76-6
Formula : C14H19NO4
M.W : 265.31
SMILES Code : O[C@@H]1[C@@H](OC(C)=O)[C@@H](CC2=CC=C(OC)C=C2)NC1
Synonyms :
Flagecidin; Wuningmeisu C; AI3-50846
MDL No. :MFCD00077650
InChI Key :YKJYKKNCCRKFSL-RDBSUJKOSA-N
Pubchem ID :253602

Safety of Anisomycin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Anisomycin

MAPK
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
AML12 cells 10 μM 2 h Activated JNK signaling pathway, increased TG accumulation, and partially deprived the therapeutic role of Tamoxifen PMC9981902
Cell monolayers derived from pig jejunum organoids 1 µM 24 h Anisomycin disrupted the epithelial barrier integrity but failed to induce a significant increase in paracellular permeability. Butyrate (BUT) prevented the disruption of epithelial barrier integrity induced by ANI. PMC11587856
SK-MES-1 0.5 µM 24 h Anisomycin pre-treatment activated p38 and HSP27 and induced apoptosis. PMC7545707
NCI-H520 0.5 µM 24 h Anisomycin pre-treatment activated p38 and HSP27 and induced apoptosis. PMC7545707
Murine neonatal cardiomyocytes 25 ng/mL 1 h Pretreatment with anisomycin partially abolished the protective effects of NG-R1 against H/R-induced cardiomyocyte apoptosis. PMC10310839

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice MCD diet-induced NASH model Intraperitoneal injection 50 mg/kg 5 consecutive days Activated JNK signaling pathway and partially abolished the therapeutic effect of Tamoxifen on hepatic steatosis PMC9981902
Rats Fear memory model Bilateral infusion into the basolateral amygdala 125 mg/ml Single administration To evaluate the effect of Anisomycin on fear memory reconsolidation blockade, results showed that Anisomycin effectively blocked memory reconsolidation in rats trained with 1P, but had no effect in rats trained with 10P. PMC7297527
Mice Depressive-like behavior model Intraperitoneal injection 100 mg/kg Single injection, behavioral tests performed 3 hours later To evaluate the effect of Anisomycin on depressive-like behavior in mice, results showed that Anisomycin increased immobility time in TST and latency to feed in NSF. PMC11442801

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.77mL

0.75mL

0.38mL

18.85mL

3.77mL

1.88mL

37.69mL

7.54mL

3.77mL

References

 

Historical Records

Categories